Status:
ENROLLING_BY_INVITATION
Effect of Coffee and Agave Inulin-based Beverage on Appetite in Adults With Obesity.
Lead Sponsor:
University of Guadalajara
Collaborating Sponsors:
Hospital Civil de Guadalajara
Conditions:
Obesity
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
Nutritional treatment is key in managing obesity; however, the lack of fullness or satiety signals may affect adherence to this treatment. Coffee and inulin consumption, separately, have been shown to...
Detailed Description
In Mexico, obesity has not ceased to increase since 1988, when it had a prevalence of only 9.5% compared to the 36.1% recorded in 2018, so it is necessary to start acting for the welfare of the Mexica...
Eligibility Criteria
Inclusion
- Men and women
- 25 to 55 years of age
- BMI ≥ 30 and \<35 kg/m2
- Habitual coffee consumption (1 - 3 cups of 240 ml of coffee per day)
- Willingness to stop consuming food and/or supplements with coffee, caffeine and/or inulin during the study with the exception of the intervention
- Availability of time in the mornings
- Residents of the Guadalajara Metropolitan Area
- Signed informed consent form
Exclusion
- Hypersensitivity or intolerance to coffee or inulin
- Allergy or intolerance to any of the test foods
- Current or within the last 6 months use of weight-loss or appetite altering medications appetite altering medications
- Diagnosis of diabetes, hypertension or any heart disease, thyroid disease, infectious disease (COVID-19, flu, etc.), digestive or inflammatory bowel disease or dysgeusia
- Smoking
- Women who are pregnant, want to become pregnant, or are breastfeeding
- Peri-menopausal or menopausal women
- Who are on any dietary regimen for weight loss
- Currently or within the last 12 months participated in another study
- Consumption of prebiotics or probiotics in the last three months
- Incomplete data and/or measurements
- Lack of expected compliance (drinking at least 5 of the 7 days of each week is considered compliance).
- Individuals who decide to leave the study
Key Trial Info
Start Date :
June 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06527209
Start Date
June 24 2024
End Date
July 31 2025
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad de Guadalajara
Guadalajara, Jalisco, Mexico, 44340